Fair opening price Current price
----------------------------------- ------------------
$1.01 $1.02 (Overvalued)
Will Titan Pharmaceuticals go up?
Will Titan Pharmaceuticals, Inc. (de) stock price grow / rise / go up? Yes. The TTNP stock price can go up from 1.015 USD to 1.063 USD in one year.
Will Ttnp reverse split?
(NASDAQ: TTNP) ("Titan" or the "Company") today announced that its Board of Directors has approved a 1-for-30 reverse stock split of the Company's common stock, which will be effective at 5:00 p.m. Eastern Time on Monday, .
Who owns Ttnp stock?
Stockholder Stake Shares owned
---------------------------- ----- ------------
The Vanguard Group, Inc. 2.06% 204,306
Morgan Stanley & Co. LLC 0.91% 90,466
Geode Capital Management LLC 0.54% 53,097
Group One Trading LP 0.15% 14,996
Is Titan Pharmaceuticals A Good Investment?
Titan Pharmaceuticals has received a consensus rating of Buy.
What does Titan Pharmaceuticals make?
Titan is a development-stage biotechnology company developing proprietary therapeutics using its clinically proven ProNeura® long-term, continuous drug delivery technology.
Where is Titan Pharmaceuticals located?
Type Public
------------ ------------------------------------------------------------------------------
Industry Pharmaceuticals
Headquarters California
Key people Executive Chairman, Marc Rubin, MD; President & COO, Kate Beebe Devarney, Ph.D
Website www.titanpharm.com
Should I buy Titan Pharmaceuticals stock?
1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Titan Pharmaceuticals in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Titan Pharmaceuticals stock.
Who owns Alna stock?
Stockholder Stake Shares owned
---------------------------- ----- ------------
The Vanguard Group, Inc. 2.40% 1,978,461
Altium Capital Management LP 1.29% 1,067,886
Morgan Stanley & Co. LLC 1.27% 1,045,481
Worth Venture Partners LLC 1.19% 980,200